Tag: Systemic sclerosis (SSc)

Severe lung involvement in SSc linked to anti-Ro/SSA antibodies

Presented By
Dr Blaž Burja, University Hospital Zurich, Switzerland
Conference
EULAR 2024
Type
Peer-reviewed article

29 July 2024 14:35

Early treatment with ambrisentan might prevent PAH development in patients with SSc

Presented By
Dr Panagiota Xanthouli, Heidelberg University Hospital, Germany
Trial
Phase 2, EDITA
Conference
EULAR 2024
Type
Peer-reviewed article

29 July 2024 14:34

Join the conversation on Rare Disease Awareness Day

Expert
Prof. Rachel Giles

26 February 2024 11:42

Targeted DMARDs advantageous in SSc patients with pre-capillary pulmonary hypertension

Presented By
Dr Cosimo Bruni, University Hospital Zurich, Switzerland
Conference
EULAR 2023
Type
Peer-reviewed article

31 July 2023 06:33

A novel risk score helps identify interstitial lung disease in patients with systemic sclerosis

Presented By
Dr Cosimo Bruni, University of Zürich, Switzerla
Conference
ACR 2022
Type
News article

1 December 2022 12:27

Antifibrotic therapy with nintedanib is beneficial for patients with negative prognostic factors

Presented By
Prof. Christopher Denton , University College London, United Kingdom
Trial
Phase 3, SENSCIS
Conference
EULAR 2022
Type
Peer-reviewed article

21 July 2022 18:07

EULAR 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
EULAR 2022

22 June 2022 23:51

JAK inhibition offers promising treatment prospects for uncommon dermatoses

Presented By
Prof. Matthew Vesely, Yale School of Medicine, USA
Conference
AAD 2022
Type
Peer-reviewed article

17 May 2022 11:48

Autotaxin inhibitor successful in the first trial in diffuse cutaneous systemic sclerosis

Presented By
Prof. Dinesh Khanna, University of Michigan Scleroderma Program, USA
Trial
Phase 2, NOVESA
Conference
ACR 2020
Type
Peer-reviewed article

18 January 2021 11:02

Subclinical myocardial involvement progresses in SSc patients

Presented By
Dr Devis Benfaremo, Università Politecnica delle Marche, Italy
Conference
EULAR 2020

14 August 2020 14:55

HS patients carry higher risk for systemic lupus erythematosus

Trial
phase 1
Conference
AAD 2020
Type
Peer-reviewed article

6 August 2020 13:04

Antifibrotic therapy slows disease progression independent of corticosteroid use

Presented By
Dr Madelon Vonk, Radboud University, the Netherlands
Trial
SENSCIS
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 23:22

Reduction of FVC decline in systemic sclerosis-associated ILD

Presented By
Dr Kristin Highland, Cleveland Clinic, Ohio, USA
Trial
SENSCIS
Conference
ERS 2019
Type
Peer-reviewed article

28 November 2019 22:14

Nintedanib reduces lung function decline in systemic sclerosis-associated ILD

Presented By
Prof. Oliver Distler, University Hospital Zurich, Switzerland
Trial
SENSCIS
Conference
ATS 2019
Type
Peer-reviewed article

23 July 2019 23:49

Promising results rituximab in systemic sclerosis, and systemic lupus erythematosus classification criteria

Presented By
Prof. Allanore, University of Paris Descartes University, France
Conference
EULAR 2018
Type
Peer-reviewed article

24 August 2018 22:49
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com